Waypoint Wealth Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $545K | Sell |
2,934
-18
| -0.6% | -$3.34K | 0.27% | 57 |
|
2025
Q1 | $618K | Sell |
2,952
-393
| -12% | -$82.3K | 0.39% | 46 |
|
2024
Q4 | $594K | Sell |
3,345
-97
| -3% | -$17.2K | 0.39% | 46 |
|
2024
Q3 | $680K | Buy |
3,442
+88
| +3% | +$17.4K | 0.46% | 42 |
|
2024
Q2 | $575K | Sell |
3,354
-45
| -1% | -$7.72K | 0.44% | 42 |
|
2024
Q1 | $619K | Buy |
3,399
+87
| +3% | +$15.8K | 0.48% | 41 |
|
2023
Q4 | $513K | Sell |
3,312
-267
| -7% | -$41.4K | 0.44% | 47 |
|
2023
Q3 | $534K | Buy |
3,579
+35
| +1% | +$5.22K | 0.5% | 41 |
|
2023
Q2 | $477K | Sell |
3,544
-2,054
| -37% | -$277K | 0.43% | 45 |
|
2023
Q1 | $892K | Buy |
5,598
+53
| +1% | +$8.45K | 0.69% | 33 |
|
2022
Q4 | $896K | Buy |
+5,545
| New | +$896K | 0.72% | 35 |
|